OpenAI’s valuation drops below $100B within 12 months

The trial’s uncertainty and potential regulatory scrutiny of AI models could erode investor confidence. A sub-$100B valuation reflects heightened risk premiums and delayed commercial milestones.

Implied probability (Yes)

60%